Novartis gets US FDA approvable letter for 'Certican'
21 October 2003 16:39 [Source: ICIS news]
LONDON (CNI)--Novartis announced Tuesday it had received an approvable letter from the US Food and Drug Administration (FDA) for its transplant drug Certican.
Final approval is contingent on Novartis’ submission and FDA review of additional data, the Swiss life sciences group said.
Certican received its first approval from the Swedish Medical Products Agency in July this year. This means that Sweden is the reference member state for the mutual recognition process that is currently underway for Certican in the European Union (EU).
In Canada, the product received fast-track designation for use in heart transplant patients and is under review for use in kidney patients.
Certican is an immunosuppresant for use in kidney and heart transplantation. It targets the primary causes of chronic tissue rejection and infection, which Novartis said is a major unmet medical need in transplantation.
By: Glenda Thisdell
+44 20 8652 3214
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
| ICIS news FREE TRIAL |
| Get access to breaking chemical news as it happens. |
| ICIS Global Petrochemical Index (IPEX) |
| ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index |
Related Articles
- 17 Mar 04 00:00 US FDA plans role in accelerating drug development work
- 17 Nov 03 15:53 AstraZeneca gets EU approval for higher dose asthma drug
- 20 Oct 03 11:55 Novartis posts 9 month pre-tax profits up 4% to $4.5bn
- 15 Oct 03 15:09 Boom and Bust for Blockbuster Drugs
- 26 Sep 03 21:26 Rising Stars in the Drug Pipeline
- 23 Jul 03 10:25 Novartis gains marketing approval from Sweden for 'Certican'
- 11 Apr 03 21:16 Novartis Enjoys Solid Product Platform and Growing Pipeline
- 27 Jul 00 19:05 Novartis wins UK Appeal Court ruling on 'Certican' patent
Latest News
- 18 Jun 13 23:59 Europe June SAN contracts settle at a rollover to slight rise
- 18 Jun 13 23:59 Solvent neutral base oil prices decrease in Europe export market
- 18 Jun 13 23:48 US vinyl flooring demand to rise 6%/yr, research firm
- 18 Jun 13 23:17 US shale oil ‘bonanza’ has not shifted global trends yet: analyst
- 18 Jun 13 23:00 EVENING SNAPSHOT - Americas Markets Summary